Psychedelic Stock Gainers And Losers From August 23, 2022
GAINERS:
GH Research (NASDAQ:GHRS) shares closed up 5.33% at $14.24
Small Pharma, Cybin Among Top Psychedelic Movers Of Today
GAINERS:
Small Pharma (OTC:DMTTF) shares closed up 10.34% at $0.16
Small Pharma, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS:
Small Pharma (OTC:DMTTF) shares closed up 29.35% at $0.14
LOSERS:
Psychedelic Biotech Gets U.K. Study Approval In Treatment Of Depression
Short-acting psychedelics company Small Pharma Inc. (OTCQB: DMTTF) has received the approval from the U.K.
Small Pharma: New Canadian Patent For Proprietary DMT Analogue, Adds To Growing International Protection Grants
Biotech producer of short-acting psychedelics for therapeutic purposes Small Pharma Inc.
Psychedelics Management Updates: Two Top Companies Appoint New CEOs, Here’s What We Know
Two companies in the psychedelics space have chosen new chief executive officers: COMPASS Pathways (NASDAQ: CMPS) has chosen Kabir Nath, and Small Pharma will be now led by George Tziras.
DMT Therapy Developer Small Pharma Posts Financial Results, Reaffirms Potential Of Short-Acting Psychedelics
Biotech company Small Pharma Inc. (OTCQB: DMTTF), producer of short-acting psychedelic-assisted therapies for diverse mental health conditions, announced its financial results earlier this month for the fiscal year ended Feb. 28, 2022.
Psychedelic Stock Gainers And Losers From June 10, 2022
GAINERS:
Cybin (AMEX:CYBN) shares closed up 6.16% at $0.67
Jefferies Global Healthcare Conference: Three Psychedelic Biotech Companies To Participate This Week
The 2022 Jefferies Global Healthcare Conference is an annual gathering where over 500 public & private healthcare companies and 3,000 leading executives, institutional investors, private equity investors & VCs address near-term and long-term investment opportunities and discuss current trends driving healthcare in the U.S. and internationally.
Cybin, Small Pharma Among Top Psychedelic Movers Of Today
GAINERS:
Cybin (AMEX:CYBN) shares closed up 15.60% at $0.68